The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F
Keywords: SNAP-tag technology; Auristatin; EGFR; HER2; ADCADC, antibody–drug conjugate; AURIF, auristatin F; MMAE, auristatin E; EGFR, epidermal growth factor receptor; HER2, human epidermal growth factor receptor 2; scFv, single chain fragment variable; IMAC, immo